Teva touts MS drug data; Merck and Numerate partner on cardio drugs;

@FierceBiotech: Shire ($SHPGY) nabs Bay Area's FerroKin, orphan drug in $325M buyout. News | Follow @FierceBiotech

@JohnCFierce: Merck offers $90M to bankroll new drug discovery institute in San Diego. Article | Follow @JohnCFierce

@RyanMFierce: Stanford developed an algorithm that offers a smarter way to analyze adverse drug reaction data. More | Follow @RyanMFierce

@FierceMedDev: ARM looks to refrigerators, medical devices with new chip, via CNET. Article | Follow @FierceMedDev

> Teva ($TEVA) has published a study demonstrating that laquinimod reduced the annual relapse rate for MS patients by 23% and disability progression by 36%. The study was published in The New England Journal of Medicine. Story

> Merck ($MRK) will collaborate with Numerate, which offers computer-based drug design work, on the discovery of new drugs for cardiovascular disease. Story

> Bayer HealthCare Pharmaceuticals says the FDA has approved a new indication for Natazia for the treatment of heavy menstrual bleeding. Release

> Stemline Therapeutics announced that Kevin Buchi has joined its board of directors. Release

Pharma News

@FiercePharma: Foreign drugmakers may be disgruntled with India's policies, but the market is too big to ignore, the ET says. Article | Follow @FiercePharma

> Stada stymied in bids for Russian M&A. Story

> Divestments 'not a trivial exercise,' Read tells FT. Item

> Forest mourns as Teva celebrates launch of generic Lexapro. More

> GSK offloads consumer brands to Omega, delays Alli sale. Article

CRO News

> NeuroNEXT adds med schools to its national CNS clinical trial network. Story

> Indian CROs accuse 'Dateline' of smearing their reputations. Article

> Big quarterly loss whacks ex-Biogen chief's CMO amid transition. More

> Animal rights activists fighting one of the last supply routes for U.K. researchers. Item

> Devicemakers eye outsourcing to limit hit from Obama tax. News

Vaccines News

> Hep C vaccine heads into further clinical trials. More

> GeoVax steps closer to HIV prevention. Story

> In the clinic, Inovio's HIV vaccine treats as well as prevents. Article

> Could a vaccine crack cocaine abuse? Item

> Hand, foot and mouth vaccine triggers 100% immune response. Story

Manufacturing News

> Pfizer's new U.K. cold storage facility has hot new vaccines line. Article

> Industry stymies effort to make it fund drug disposal program. Piece

> J&J's Weldon to get $143M in retirement. Item

> Sanofi cuts continue with closing of manufacturing plant in U.K. More

And Finally… Investigators at the University of Rochester Medical Center and the University of Southern California say they have developed a new compound that proved promising for Alzheimer's in an animal study. Report

Suggested Articles

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.

Gilead presented studies at AASLD showing how noninvasive testing and machine learning could improve diagnostics and drug development for NASH.